PREEMPT CRC

 The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy

Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this prospective multi-center observational study is to validate a blood-based test for the detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Location:SIMR (Sacramento/Valley Area)

Please contact Debbie Jacobs jacobsDA@sutterhealth.org about study PREEMPT CRC

Principal Investigator

Charles McDonnell, MD, FACR

Co-Investigator(s)

Ian J Logan, MD, Theodor Feinstat, MD, Andrew Hudnut, MD, Abdul M Khaleq, MD 

Recruitment Status

Active, Recruiting

Start Date

January 21, 2021